<?xml version="1.0" encoding="UTF-8"?>
<document id="29136674">
	<sentence id="s1" text="Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (detection of calcium ion) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.">
		<entity id="s1.e1" charOffset="26-45"
			type="HP" text="hyperparathyroidism" ontology_id="HP_0000843"/>
		<entity id="s1.e2" charOffset="86-99"
			type="HP" text="hypercalcemia" ontology_id="HP_0003072"/>
		<entity id="s1.e3" charOffset="101-125"
			type="GO" text="detection of calcium ion" ontology_id="GO_0005513"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="true"/>
	</sentence>
	<sentence id="s2" text="It usually reflects biallelic inactivation of the li>CASR.</i> 3) Multiple endocrine neoplasia cardiac muscle tissue development 1 (negative regulation of transcription by RNA polymerase II) is most frequently expressed as PHPT with asymmetric enlargement of 3-4 parathyroids.">
		<entity id="s2.e1" charOffset="85-94"
			type="HP" text="neoplasia" ontology_id="HP_0002664"/>
		<entity id="s2.e2" charOffset="95-128"
			type="GO" text="cardiac muscle tissue development" ontology_id="GO_0048738"/>
		<entity id="s2.e3" charOffset="132-189"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="true"/>
	</sentence>
	<sentence id="s3" text="4) Multiple endocrine neoplasia cardiac muscle tissue development 2A from li>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.">
		<entity id="s3.e1" charOffset="22-31"
			type="HP" text="neoplasia" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="32-65"
			type="GO" text="cardiac muscle tissue development" ontology_id="GO_0048738"/>
		<entity id="s3.e3" charOffset="133-152"
			type="HP" text="hyperparathyroidism" ontology_id="HP_0000843"/>
		<entity id="s3.e4" charOffset="180-186"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e5" charOffset="191-207"
			type="HP" text="pheochromocytoma" ontology_id="HP_0002666"/>
		<pair id="s3.p1" e1="s3.e3"
		    e2="s3.e3" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
		<pair id="s3.p3" e1="s3.e2"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p4" e1="s3.e2"
		    e2="s3.e5" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Five of the PHPT syndromes reflect overgrowth of parathyroid tissue; in contrast, familial hypocalciuric hypercalcemia reflects dysregulation of negative regulation of transcription by RNA polymerase II secretion with little or no parathyroid overgrowth.">
		<entity id="s4.e1" charOffset="105-118"
			type="HP" text="hypercalcemia" ontology_id="HP_0003072"/>
		<entity id="s4.e2" charOffset="145-202"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
</document>
